logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Khan, Sohail Naseem
    Director born in June 1988
    Individual (5 offsprings)
    Officer
    icon of calendar 2011-09-02 ~ now
    OF - Director → CIF 0
    Mr Sohail Naseem Khan
    Born in June 1988
    Individual (5 offsprings)
    Person with significant control
    icon of calendar 2016-07-01 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

SNK PHARMA LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Property, Plant & Equipment
3 GBP2024-09-30
6 GBP2023-09-30
Fixed Assets
3 GBP2024-09-30
6 GBP2023-09-30
Debtors
49,185 GBP2024-09-30
48,934 GBP2023-09-30
Cash at bank and in hand
6,896 GBP2024-09-30
5,947 GBP2023-09-30
Current Assets
56,081 GBP2024-09-30
54,881 GBP2023-09-30
Creditors
Amounts falling due within one year
-4,111 GBP2024-09-30
-11,062 GBP2023-09-30
Net Current Assets/Liabilities
51,970 GBP2024-09-30
43,819 GBP2023-09-30
Total Assets Less Current Liabilities
51,973 GBP2024-09-30
43,825 GBP2023-09-30
Creditors
Amounts falling due after one year
-34,954 GBP2024-09-30
-40,486 GBP2023-09-30
Net Assets/Liabilities
17,019 GBP2024-09-30
3,339 GBP2023-09-30
Equity
Called up share capital
100 GBP2024-09-30
100 GBP2023-09-30
Retained earnings (accumulated losses)
16,919 GBP2024-09-30
3,239 GBP2023-09-30
Equity
17,019 GBP2024-09-30
3,339 GBP2023-09-30
Average Number of Employees
22023-10-01 ~ 2024-09-30
22022-10-01 ~ 2023-09-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
4,326 GBP2024-09-30
4,326 GBP2023-09-30
Property, Plant & Equipment - Gross Cost
4,326 GBP2024-09-30
4,326 GBP2023-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
4,323 GBP2024-09-30
4,320 GBP2023-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
4,323 GBP2024-09-30
4,320 GBP2023-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
3 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
3 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment
Plant and equipment
3 GBP2024-09-30
6 GBP2023-09-30
  • SNK PHARMA LIMITED
    Info
    Registered number 07760088
    icon of address23 Dearman Road, Sparkbrook, Birmingham B11 1HH
    Private Limited Company incorporated on 2011-09-02 (14 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 16 October 2025 and licensed under the Open Government Licence v3.0.